PharmaCell specializes in cell-culturing services using its GMP-certified manufacturing facilities in Maastricht and Geleen. Its customers include the world leaders in commercial cell therapy products. Pharmacell has access to an extensive network which gives it the capability to provide support and/or partnership to R&D companies to bring new products from the lab into the clinic.
Latest PharmaCell News
Oct 18, 2018
17:10 EDT 18 Oct 2018 | BioPortfolio Reports Summary PharmaCell BV PharmaCell is a contract manufacturing organization that offers services for cellular therapies and regenerative medicine . The organization manufactures commercial cell therapy products in the European markets. Its services include cell culture scaleup, manufacturing of advanced therapeutic medicinal products, process development, transfer of technologies and controlled temperature transportation. PharmaCell provides capacity reservation and patient treatment scheduling and shipper validation, among others. The organization offers its services in the areas of operations, technology transfer, process development and logistics. It manufactures clinical trial material in Phase I to Phase III clinical trials. PharmaCell is headquartered in Maastricht, the Netherlands. PharmaCell BV Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
PharmaCell Frequently Asked Questions (FAQ)
Where is PharmaCell's headquarters?
PharmaCell's headquarters is located at Oxfordlaan 70, Maastricht.
What is PharmaCell's latest funding round?
PharmaCell's latest funding round is Acquired.
How much did PharmaCell raise?
PharmaCell raised a total of $2.63M.
Who are the investors of PharmaCell?
Investors of PharmaCell include Lonza Group, Brightlands Venture Partners, Maastricht University Hospital and Mercurius Beleggingsmaatschappij BV.